(Q46259715)
Statements
1 reference
A phase II trial of high-dose imatinib mesylate for relapsed or refractory c-kit positive and Bcr-Abl negative acute myeloid leukaemia: the AFR-15 trial (English)
1 reference
Patrice Chevallier
1 reference
Mathilde Hunault-Berger
1 reference
Fabrice Larosa
1 reference
Charles Dauriac
1 reference
Richard Garand
1 reference
Jean-Luc Harousseau
1 reference
5 November 2008
1 reference
1 reference
33
1 reference
8
1 reference
1124-1126
1 reference
Identifiers
1 reference
1 reference